venBio Partners

Summary

The venture was found in North America in United States. The leading representative office of defined VC is situated in the San Francisco.

We can highlight the next thriving fund investment areas, such as Genetics, Therapeutics. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Adaptimmune, Harmony Biosciences, Checkmate Pharmaceuticals. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund.

The current fund was established by Corey Goodman, Kurt von Emster, Robert Adelman. The overall number of key employees were 1.

The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this VC is 18 percentage points more often commits exit comparing to other companies. Opposing the other organizations, this venBio Partners works on 12 percentage points more the average amount of lead investments. The top activity for fund was in 2018. The common things for fund are deals in the range of 50 - 100 millions dollars. The average startup value when the investment from venBio Partners is 100-500 millions dollars. The top amount of exits for fund were in 2019.

The standard case for the fund is to invest in rounds with 5-6 partakers. Despite the venBio Partners, startups are often financed by Remeditex Ventures, Sofinnova Investments, F-Prime Capital. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, F-Prime Capital, Sofinnova Investments. In the next rounds fund is usually obtained by Vivo Capital, F-Prime Capital, Cormorant Asset Management.